Project Grant R21AI190507
Award Date
4/23/25
Completion Date
3/31/27
Dollars Obligated
$265K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Washington, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $737,502 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Washington University in St. Louis. The grant, titled "Role of WDFY4 in Treg Development," will fund research to investigate a novel pathway involving the WDFY4 protein that regulates antigen presentation by dendritic cells and is critical for the development and function of regulatory T cells (Tregs). The...
The federal Project Grant award R01AI179712, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the balance of pro- and anti-inflammatory signals that regulate the function of CD8 T cells in human tissues. The $857,346 award, spanning 2025 to 2029, will enable the Fred Hutchinson Cancer Center to define the specific cytokine and metabolite signals present in healthy...
This $162,512 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to determine how pathogen exposure and inflammation impact the expansion and function of long-lived effector CD8 T cells in the memory compartment. The award will enable the Regents of the University of Minnesota, a prominent land-grant research institution, to conduct experiments to identify...
This $693,465 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) is funding a research project at Cornell University focused on mapping the development of T cell immunity in lymph nodes from infancy to adulthood. The key objectives are to: 1) determine how the spatial organization of T cells changes in the lymph node throughout childhood, 2) examine how the lymph node shapes the...
This $195,894 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Washington University in St. Louis. The grant will fund a 5-year research project to study the mechanisms contributing to T cell dysregulation in STAT3 gain-of-function syndrome, a primary immune regulatory disorder. The research aims to gain a deeper understanding of critical interactions between T and B...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $246,623 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to New York University School of Medicine to conduct research on the molecular control of tolerogenic dendritic cell function. The research aims to pinpoint the specific dendritic cell subset responsible for regulating immune tolerance, characterize the molecular basis including aberrant cytokine production and signaling impairment, and...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $128,250 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Fred Hutchinson Cancer Center in Seattle, WA. The grant aims to develop safer and more specific chimeric antigen receptor (CAR) T cell therapies targeting the PD-1 protein expressed on latently HIV-infected T follicular helper cells. This research seeks to enable the elimination of persistent HIV viral reservoirs in the...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $402,731 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Washington. The grant will support training for four physician-scientists in pediatrics or obstetrics/gynecology residency to complete one year of laboratory-based immunology or infectious disease research. The program aims to increase the number of physician-scientists who can apply microbiology,...
The University of Washington was awarded a $350,000 Project Grant under the National Institute of Allergy and Infectious Diseases' (NIAID) Allergy and Infectious Diseases Research program (CFDA 93.855). The grant, with an award date of August 9, 2024 and an ultimate completion date of June 30, 2025, will fund research to investigate the role of the "necroptosis" cell death pathway in activating inflammatory transcription programs and modulating the immune response to influenza A...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $187,398 to investigate the role of the programmed death ligand-1 (PD-L1) in regulating dendritic cell migration and T cell priming. The primary objectives are to: 1) Define which extracellular interactions between PD-L1 and CD80 regulate dendritic cell migration, and 2) Determine how PD-L1 intracellular signals...